Search

everythinglearnresearchcommunity

for

Search:↓

Certain immune markers may predict chemotherapy response in mesothelioma, and nivolumab is a tolerable and effective treatment for advanced non-small cell lung cancer.

Super-enhancers control CD25 expression in specific cell types, affecting immune function.

The role of γδT-cells in causing alopecia areata remains unclear.

Enhancing Tregs can protect against alopecia areata.

Alopecia areata patients have more activated T cells in their blood, which may help in developing treatments.

Modulating the BTNL2 pathway can prevent hair loss in mice.

CD8+ T cells re-expressing CD45RA may predict treatment resistance in severe alopecia areata.

The research found that the molecule lncRNA-H19 helps hair follicle cells grow by affecting certain cell pathways in cashmere goats.

Contact immunotherapy can change immune responses in alopecia areata, suggesting new treatment targets.

Vδ1+ T-cells in the skin contribute to hair loss in alopecia areata and could be targeted for treatment.

Sex and race affect immune responses and treatment outcomes in Hidradenitis suppurativa.

Certain immune cells in atopic dermatitis skin could be targeted for treatment.

Dormant melanoma cells in mice interact minimally with memory T cells due to a suppressive tumor environment.

Belatacept may be a promising treatment for alopecia areata.

Hair follicles help skin immune recovery after UVB exposure.

The number of new cases of cutaneous B-cell lymphoma has leveled off since the early 2000s, and survival rates have improved since 1973.

Higher levels of IL-1R1 and hsa-miR-19b-3p may help diagnose and predict alopecia areata severity.

CD4 T cells need IFN-γ to cause hair loss in alopecia areata.

Blocking CD44 can reduce leukocyte migration in autoimmune skin diseases.

Basal cell carcinomas may use IDO to protect themselves from the immune system.

Bexxar is highly effective as a first treatment for non-Hodgkin's lymphoma, with most patients alive and many in remission after eight years.

People with acne have more CD4+ immune cells in their skin than healthy people.

Expanding CD4+ Tregs can stop hair loss in alopecia areata.

Memory T cells in the skin balance staying put and moving into the blood, clustering around hair follicles, and increasing in number after infection.

CD99 is highly present in certain skin cells and could help treat skin conditions.

Using CD123 to detect certain immune cells helps diagnose a type of hair loss condition.